ReviewRSC advances2026
Surface engineering and functionalization of powder-based materials by fluidized-bed atomic layer deposition for emerging applications.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transformational Catalytic Innovation Supports COChemistryOpen · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing need for advanced materials with tunable properties has triggered an increasing interest in innovative surface modification techniques. Fluidized-bed atomic layer deposition (FB-ALD) offers a powerful solution for surface engineering and functionalization of powder-based materials for a variety of applications. By relying on its capability for controlling uniformity and conformality of the coatings precisely at the atomic scale, ALD can effectively modify surface characteristics to improve the functionality and durability of the materials. In this review, we will provide comprehensive fundamentals and strategies to improve the fluidization of nanopowders and reveal the potential of FR-ALD in two emerging applications. The first application is in energy devices, where FB-ALD is employed to develop Pt-based electrocatalysts for fuel cells and other catalytic reactions. We demonstrate that FB-ALD enables precise control of size, composition, and dispersion of Pt nanoparticles over the support surface, resulting in a strong enhancement in catalytic performance. We additionally discuss the application of FB-ALD in boosting the stability and durability of catalysts by surface engineering with ultrathin films and ultrasmall nanoparticles without compromising their activity. These capabilities open new avenues for the development of high-performance and durable catalysts for energy applications. The second application is in pharmaceutical research, where FB-ALD is employed to coat active pharmaceutical ingredients with thin films of biocompatible materials, such as Al
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.